# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001571049-16-013493
Filing Date
2016-03-30
Accepted
2016-03-30 17:20:53
Documents
5
Period of Report
2016-05-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRELIMINARY PROXY STATEMENT | t1600894_pre14a.htm | PRE 14A | 395661
2 | GRAPHIC | t1600894_pc-pg01.jpg | GRAPHIC | 320375
3 | GRAPHIC | t1600894_pc-pg02.jpg | GRAPHIC | 252634
4 | GRAPHIC | t1600894_pc-pg03.jpg | GRAPHIC | 250073
5 | GRAPHIC | t1600894_pc-pg04.jpg | GRAPHIC | 198989
| Complete submission text file | 0001571049-16-013493.txt |  | 1788596

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-50626 | Film No.: 161540804
SIC: 2834 Pharmaceutical Preparations